Researchers reveal mechanism of protection against breast and ovarian cancer
In a new paper published in Nature, researchers at the Francis Crick Institute, UK, have outlined…
In a new paper published in Nature, researchers at the Francis Crick Institute, UK, have outlined…
New study shows exactly how the gene BRCA2, linked to susceptibility to breast and ovarian…
Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly…
The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been recommended…
The Institute of Cancer Research, London, UK, strongly welcomes new findings that the targeted drug…
Results from a global clinical trial have shown a 32% reduction in breast cancer deaths…
Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk…
Several years ago, it was discovered that a group of women with hereditary breast and…
Talazoparib, a new precision drug, can keep cancer in check in some men with advanced prostate…
An antibiotic developed in the 1950s and largely supplanted by newer drugs, effectively targets and…